Radiation-induced CD8 T-lymphocyte Apoptosis as a Predictor of Breast Fibrosis After Radiotherapy: Results of the Prospective Multicenter French Trial☆

[1]  M. Pike,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.

[2]  P. Canney,et al.  Transforming growth factor beta: a promotor of late connective tissue injury following radiotherapy? , 1990, The British journal of radiology.

[3]  R. Arriagada,et al.  Competing risks determining event-free survival in early breast cancer. , 1992, British Journal of Cancer.

[4]  M S Pepe,et al.  Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? , 1993, Statistics in medicine.

[5]  J. Lebesque,et al.  Lack of correlation of human fibroblast radiosensitivity in vitro with early skin reactions in patients undergoing radiotherapy. , 1993, International journal of radiation biology.

[6]  S M Bentzen,et al.  Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  J. Overgaard,et al.  Radiotherapy-related lung fibrosis enhanced by tamoxifen. , 1996, Journal of the National Cancer Institute.

[8]  L Fallowfield,et al.  Does cosmetic outcome from treatment of primary breast cancer influence psychosocial morbidity? , 1999, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[9]  J. Fine,et al.  Regression modeling of competing crude failure probabilities. , 2001, Biostatistics.

[10]  Benjamin Reiser,et al.  mROC: a computer program for combining tumour markers in predicting disease states , 2001, Comput. Methods Programs Biomed..

[11]  C. N. Coleman,et al.  CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. , 2003, Seminars in radiation oncology.

[12]  R. Mirimanoff,et al.  Concomitant use of tamoxifen with radiotherapy enhances subcutaneous breast fibrosis in hypersensitive patients , 2004, British Journal of Cancer.

[13]  R. Mirimanoff,et al.  CD4 and CD8 T-Lymphocyte Apoptosis Can Predict Radiation-Induced Late Toxicity: A Prospective Study in 399 Patients , 2005, Clinical Cancer Research.

[14]  W. Sauerbrei,et al.  REporting recommendations for tumor MARKer prognostic studies (REMARK) , 2006, Breast Cancer Research and Treatment.

[15]  J. Overgaard,et al.  Effect of adjuvant systemic treatment on cosmetic outcome and late normal-tissue reactions after breast conservation , 2007, Acta oncologica.

[16]  R. Mirimanoff,et al.  Single Nucleotide Polymorphisms, Apoptosis, and the Development of Severe Late Adverse Effects After Radiotherapy , 2008, Clinical Cancer Research.

[17]  D. Boreham,et al.  Radiation-induced lymphocyte apoptosis to predict radiation therapy late toxicity in prostate cancer patients. , 2009, International journal of radiation oncology, biology, physics.

[18]  P. Lara,et al.  Radiation induced apoptosis and initial DNA damage are inversely related in locally advanced breast cancer patients , 2010, Radiation oncology.

[19]  P. Lara,et al.  Prediction of clinical toxicity in locally advanced head and neck cancer patients by radio-induced apoptosis in peripheral blood lymphocytes (PBLs) , 2010, Radiation oncology.

[20]  K. Zaman,et al.  Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial. , 2010, The Lancet. Oncology.

[21]  P. Lara,et al.  Role of CD4 and CD8 T-lymphocytes, B-lymphocytes and Natural Killer cells in the prediction of radiation-induced late toxicity in cervical cancer patients , 2011, International journal of radiation biology.

[22]  M. Ozsahin,et al.  Identifying patients at risk for late radiation-induced toxicity. , 2012, Critical reviews in oncology/hematology.

[23]  J. Solassol,et al.  Proteomic approaches to identify biomarkers predictive of radiotherapy outcomes , 2013, Expert review of proteomics.

[24]  P. Lambin,et al.  Predicting outcomes in radiation oncology—multifactorial decision support systems , 2013, Nature Reviews Clinical Oncology.

[25]  P. Lara,et al.  Radio-induced apoptosis of peripheral blood CD8 T lymphocytes is a novel prognostic factor for survival in cervical carcinoma patients , 2014, Strahlentherapie und Onkologie.

[26]  Joseph O Deasy,et al.  STROGAR – STrengthening the Reporting Of Genetic Association studies in Radiogenomics , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[27]  J. Carles,et al.  Relationship between radiation-induced apoptosis of T lymphocytes and chronic toxicity in patients with prostate cancer treated by radiation therapy: a prospective study. , 2014, International journal of radiation oncology, biology, physics.

[28]  P. Lambin,et al.  The REQUITE project: validating predictive models and biomarkers of radiotherapy toxicity to reduce side-effects and improve quality of life in cancer survivors. , 2014, Clinical oncology (Royal College of Radiologists (Great Britain)).

[29]  J. Chang-Claude,et al.  XRCC1 Polymorphism Associated With Late Toxicity After Radiation Therapy in Breast Cancer Patients. , 2015, International journal of radiation oncology, biology, physics.

[30]  M. Rezai,et al.  Impact of Age, Obesity and Smoking on Patient Satisfaction with Breast Implant Surgery – A Unicentric Analysis of 318 Implant Reconstructions after Mastectomy , 2015, Geburtshilfe und Frauenheilkunde.